Highlights of AACR 2012 – Part 3
Aside from the already published Part 1 and Part 2 blog posts about AACR here on PSB, you can also find some more coverage, including summaries of other topics, on the companion Biotech Strategy Blog, such as the following:
- SARDs, an emerging potential new class of agents for advanced prostate cancer
- Cool robots that automate cell profiling in cancer research
- Update on next generation Bcl–2 inhibitors in CLL
- Novel-novel combinations are emerging in cancer research